Dataset of eyeblink conditioning in mice treated with the selective mGluR1 antagonist JNJ16259685

Shoichi Tohyama1, Yasushi Kishimoto1

  • 1Laboratory of Physical Chemistry, Faculty of Pharma-Science, Teikyo University, Japan.

Data in Brief
|February 17, 2023
PubMed

Insights

JNJ16259685, a metabotropic glutamate receptor type 1 (mGluR1) antagonist, did not affect eyeblink conditioning in mice. This suggests mGluR1 may not be critical for motor learning processes like conditioned eyeblink responses.

Area of Science:

  • Neuroscience
  • Behavioral Neuroscience
  • Pharmacology

Background:

  • Eyeblink conditioning is a form of associative motor learning.
  • The cerebellum and brainstem are critical for motor learning.
  • Metabotropic glutamate receptor type 1 (mGluR1) involvement in motor learning is not fully understood.

Purpose of the Study:

  • To investigate the effect of JNJ16259685, a selective mGluR1 antagonist, on eyeblink conditioning in wild-type mice.
  • To provide behavioral data on the role of mGluR1 in motor learning.

Main Methods:

  • Wild-type C57BL/6J mice were used.
  • Eyeblink conditioning was assessed.
  • Behavioral outputs including conditioned response percentage (CR%), peak CR latency, onset CR latency, and electromyography (EMG) amplitude were measured.
  • Statistical analysis included t-tests and ANOVA.

Main Results:

  • JNJ16259685 did not significantly alter the percentage of conditioned responses.
  • No significant effects were observed on peak CR latency, onset CR latency, or EMG amplitude.
  • The mGluR1 antagonist did not impair eyeblink conditioning performance.

Conclusions:

  • The selective mGluR1 antagonist JNJ16259685 does not appear to affect eyeblink conditioning in wild-type mice.
  • These findings suggest that mGluR1 may not play a critical role in the motor learning processes underlying eyeblink conditioning.
  • The dataset provides valuable information for future research on the pharmacological modulation of motor learning.

Related Concept Videos